| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.5M | -20.7% |
| R&D Expense | $63.9M | +32.9% |
| SG&A Expense | $36.2M | -4.4% |
| Operating Income | -$108.9M | +5.7% |
| Pre-tax Income | -$103.0M | +6.7% |
| Income Tax | $70K | -30.0% |
| Net Income | -$103.1M | +6.7% |
| EPS (Basic) | -$0.94 | +21.7% |
| EPS (Diluted) | -$0.94 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.2M | -43.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $133.8M | +11.0% |
| Total Assets | $213.6M | -1.7% |
| Current Liabilities | $28.7M | -3.1% |
| Long-term Debt | $4.0M | -49.6% |
| Total Liabilities | $34.5M | -16.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.4M | -12.0% |
| Capital Expenditures | $404K | -53.0% |
| Investing Cash Flow | -$41.6M | -150.7% |
| Financing Cash Flow | $82.5M | +1940.9% |
| Free Cash Flow | -$72.8M | -11.2% |
| +21.7% |
| Stockholders' Equity |
| $179.1M |
| +1.7% |